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1 |  INTRODUCTION
We report a 63-year-old man, who developed bilateral atrophic 
arm paresis with preserved reflexes. Criteria for probable, lab-
oratory-supported ALS (El Escorial) were fulfilled. However, 
cerebrospinal spinal fluid analysis revealed neuroborreliosis. 
We give a detailed description of our patient's case and review 
literature on neuroborreliosis-associated ALS mimics.
The pathophysiology of ALS is incompletely understood, 
and despite reports on promising first candidates,1,2 objective 
diagnostic biomarkers are lacking. Hence, the diagnosis is 
mainly based on clinical signs and symptoms, and the results 
of neurophysiological studies.3-7 Since no causative treat-
ment is available, the differentiation from other potentially 
treatable neurological diseases that may mimic ALS symp-
toms is vital. Here, we report a patient with typical manifesta-
tions of motor neuron disease and the chance finding of acute 
neuroborreliosis.
2 |  CASE REPORT
2.1 | Patient history
The 63-year-old man was admitted for second opinion 
with the suspected diagnosis of a motor neuron disease. 
He was seen at three visits (July, August, and December 
2018). The patient had been healthy until February 2018, 
but then developed progressive muscle weakness starting 
at his left proximal arm. In March 2018, he noticed ubiqui-
tous fasciculations and generalized muscle wasting includ-
ing his legs without paresis of lower extremities. In July 
2018, that is, within six months, he developed paraparesis 
of both arms and also suffered from cramps in the shoulder 
girdle and hand muscles. By August 2018, the patient was 
severely impaired in everyday life activities. He had never 
experienced sensory symptoms or pain. The patient re-
ported a tick bite in September 2017, however, without the 
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Abstract
Comprehensive investigation in motor neuron disease is vital not to miss a treat-
able differential diagnosis. Neuroborreliosis should be considered during an ALS 
work-up. However, false-positive CSF results do occur, and thus, results should be 
interpreted carefully in context of all clinical test results.
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development of an erythema migrans. Except for type II di-
abetes mellitus which was treated with metformin 1000 mg 
per day and a cervical spinal canal stenosis without signs of 
myelopathy, the patient did not have relevant diseases. No 
further regular medication was taken. The family history 
was uninformative with regard to neuromuscular diseases. 
He did not drink alcohol regularly and had stopped smok-
ing 20 years ago.
2.2 | Neurological examination
At his first neurological examination, in July 2018 no rel-
evant bulbar symptoms were found except for mild fascicu-
lations of the tongue. Facial nerve functions and swallowing 
were normal. Tests for motor function revealed the fol-
lowing paresis according to the Medical Research Council 
Scale (MRC; results given as right/left side): head flexion 
4/5, shoulder abduction 3-4/4−, shoulder adduction 4+/4+, 
shoulder internal rotation 4+/4−, shoulder external rotation 
2-3/2-3, arm flexion 4+/4−, arm extension 4+/2-3, arm supi-
nation 4+/1-2, arm pronation 4+/4, hand flexion 5/5-, hand 
extension 5-/4+, finger extension 5-/4+, finger spreading 
4+/4−, bilateral deficits in finger adduction and especially 
finger 5, thumb abduction 4/4, thumb adduction 5/5−, thumb 
flexion 5/4, and thumb extension 5/4−. So, asymmetric distal 
and proximal atrophic arm paresis (left > right) was found 
while the lower extremities were spared. Muscle tone was 
flaccid. Muscle atrophy was seen at the shoulder girdle and 
fasciculations at all four extremities. Deep tendon reflexes at 
the upper extremities were normal, while they were reduced 
at the lower extremities. Babinski's sign was negative. The 
sensory and coordination systems were spared. On the re-
vised ALS Functional Rating Scale (ALS-FRS),8 the patient 
reached 43 (0-47) points.
2.3 | Laboratory tests
Extensive laboratory tests were normal, except for mild in-
crease in serum creatine kinase levels (224 [0-190]  U/l). 
Diabetes mellitus was controlled with a current HbA1c of 
7.2% (4%-6%) and mild glucosuria and ketonuria.
2.4 | Nerve conduction studies
There was shown a motor and axonal neuropathy without 
conduction blocks. Axonal loss was found with reduction of 
CMAP amplitudes of the left ulnar nerve (distal stimulation: 
11.0 mV, proximal stimulation below ulnar sulcus: 9.2 mV, 
and proximal stimulation above ulnar sulcus: 8.2 mV), left 
median nerve (distal stimulation: 2.9 mV and proximal stim-
ulation: 2,7 mV), and left peroneal nerve (distal stimulation: 
8.0 mV, proximal stimulation below fibular head: 3.7 mV, 
and proximal stimulation above fibular head: 3.4 mV). Distal 
motor latency and nerve conduction velocity as well as sen-
sory nerve conduction studies were normal.
2.5 | Electromyography
Electromyography (tongue, masseter, deltoid, interosseus 
dorsalis I, anterior tibial muscles, paravertebral muscles (th8 
level), and femoral muscles) showed hints for chronic and 
acute denervation with spontaneous activity (fibrillations, 
positive sharp waves, and fasciculations; Figure 1). The 
tongue was spared.
2.6 | Evoked potentials
Motor evoked potentials did not show signs of pyramidal im-
pairment or an involvement of the first motor neuron when 
obtained from the legs and the arms.
2.7 | Imaging results
Cranial and spinal MRI did not show any definitive pathol-
ogy. However, cranial MRI showed a slight increase in signal 
intensity along the pyramidal tract on the proton-weighted 
sequences. Additionally, the right median nerve was investi-
gated using high-resolution ultrasonography (18 MHz probe, 
transversal plane) and showed normal cross-sectional area 
and echogenicity. All muscles investigated (biceps, triceps, 
flexor digitorum, and infra- and suprahyoidal muscles) ubiq-
uitously showed deep and superficial fasciculations (Video 
F I G U R E  1  Excerpt from the 
electromyographic recording of the left first 
dorsal interosseous muscle. Fibrillations 
(arrows) and sporadic positive sharp waves 
(arrow heads) are seen
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S1). Muscles of the upper extremities were atrophic and 
hyperechogenic.
2.8 | Cerebrospinal fluid analysis and 
infectiological laboratory
Analysis of the cerebrospinal fluid (CSF) in August 2018 
revealed a pleocytosis (27 [1-4] n/mm3) and increased pro-
tein (111 [0-50] mg/dL), albumin (89.3 [0-53] mg/dL), and 
lactate (2.7 [1.2-2.1] mmol/L) levels, as well as an increased 
albumin ratio (18.6 [9]). It is of note that the initial lumbar 
puncture was accidentally traumatic and hence showed eryth-
rocyte contamination (43.200 [0-<1] n/mm3), which was first 
interpreted as causative for the pleocytosis. However, while 
virologic examination of CSF was normal, microbiological 
analysis surprisingly revealed positive IgM and IgG titers for 
antibodies against borrelia burgdorferi. Laboratory tests were 
performed in serum and CSF. First, an ELISA was done for 
screening and results were confirmed using an immunoblot. 
Serum tests (both with ELISA and immunoblot) were posi-
tive for IgG and negative for IgM. In line with recommended 
standards, the relevant antibody index was assessed, which 
was increased in terms of IgM antibody index 2.3 (<1.4)), 
while the IgG antibody index was normal. Furthermore, labo-
ratory tests on VDRL, VZV, HSV1/2, and FSME were per-
formed. Test results in CSF were each negative; in serum, a 
constellation indicative of past HSV and VZV infection was 
found and for FSME immunization, while results for serum 
VDRL were negative and therefore not further analyzed in 
CSF. Thus, the diagnosis of neuroborreliosis was made.
3 |  TREATMENT AND CLINICAL 
COURSE
Upon the microbiological CSF finding, we applied antibi-
otic treatment with iv ceftriaxone 2 g per day for 3 weeks. 
During hospitalization, no relevant improvement was ob-
served. However, the IgM titer for antibodies against borrelia 
burgdorferi was negative, the IgM and IgG antibody index 
normal, while the IgG titer was still elevated as a sign for 
past infection. All other CSF parameters remained elevated, 
but mildly decreased: protein (89.6 [0-50] mg/dL), albumin 
(66.8 [0-53] mg/dL), lactate (2.5 [1.2-2.1] mmol/L), and the 
albumin ratio (16.5 [9]).
4 |  FOLLOW-UP
In December 2018, 11  weeks after a 4-week rehabilitation 
therapy, the patient was re-examined at our department. 
Unfortunately, he negated any improvement upon completion TA
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of the antibiotic and rehabilitative treatment. While relevant 
bulbar symptoms were still missing, he reported progressive 
weakness of his arms and now also of his legs. Neurological 
examination showed a tetraparesis with further reduction 
in strength of arm flexors and new paresis of toe extensors. 
Deep tendon reflexes were preserved and brisk even in pa-
retic muscles and the tongue showed progressive atrophy and 
fasciculations. Pseudobulbar symptoms or other signs of an 
involvement of the upper motor neuron were missing. The 
ALS-FRS had dropped to 40 (0-47) points. Nerve conduc-
tion studies revealed a mild progression in motor, and axonal 
neuropathy and electromyography showed spontaneous ac-
tivity now also in the biceps muscle. Deep and superficial 
fasciculations were still visible during HRUS including the 
infra- and suprahyoidal muscles. Motor evoked potentials 
elicited after cortical stimulation and recording from the arms 
showed mild dispersion of potentials, while central and pe-
ripheral latencies were normal.
5 |  DIFFERENTIAL DIAGNOSIS
Antibiotic treatment and subsequent rehabilitation did not im-
prove symptoms or slow down disease progression. Hence, it 
is unlikely that neuroborreliosis was the main cause of symp-
toms in our patient. Since one year after symptom onset, 
next to signs of a lower motor neuron impairment, few, but 
definite clinical signs of an upper motor neuron impairment 
(preserved reflexes despite atrophic progressive paresis) and 
electrophysiological signs of acute and chronic denervation 
were found, the El Escorial criteria for probable, laboratory-
supported ALS and Awaji criteria for possible ALS were ful-
filled.4,5 Initial clinical presentation suggested the differential 
diagnosis of a flail arm syndrome9; however, fasciculations 
of the tongue and paresis of lower extremities developing 
with time suggest an early stage of ALS.
6 |  DISCUSSION
We report a patient, who developed atrophic paresis of his 
arm muscles over six months, initially presenting with asym-
metric paresis, fasciculations of the tongue, and preserved re-
flexes in the clinical examination, and the incidental finding 
of neuroborreliosis analyzing CSF. Literature search revealed 
few case reports of patients with a motor neuron impairment 
caused by neuroborreliosis (Table 1).10,11 While the patho-
physiology remains elusive, these patients had ample clinical 
signs of combined spastic and atrophic tetraparesis, bulbar 
symptoms, and lymphogenic pleocytosis as well as micro-
biological evidence of neuroborreliosis in CSF analysis.10,11
Similarly, our patient developed progressive tetrapare-
sis beginning at the upper limbs. Clinical findings together 
with nerve conduction studies indicated at least a probable, 
laboratory-supported ALS. CSF analysis gave hints for neu-
roborreliosis though and the patient reported a tick bite in 
temporary context with symptom onset. However, in contrast 
to the cases reported in literature, our patient did not ben-
efit from the antibiotic therapy, but showed sustained pro-
gression. The clinical course and missing effect of antibiotic 
treatment suggest that CSF findings were incidental and that 
the main diagnosis is rather ALS.
The pathomechanism of neuroborreliosis is unclear. 
Borrelia burgdorferi may directly impair neural structures 
and may mediate autoimmune processes via B- and T-cell 
activation.12 A cross-reaction between flagellin of borrelia 
T A B L E  2  Small case series suggesting neuroborreliosis as a relevant differential diagnosis of motor neuron disease and large studies showing 
no association between neuroborreliosis and amyotrophic lateral sclerosis
Reference
Number of patients with 
amyotrophic lateral sclerosis
Number of patients with serological 
evidence of neuroborreliosis
Association between amyotrophic lat-
eral sclerosis and neuroborreliosis
Halperin et al 
(1990)15
19 9 (ELISA and Lyme borreliosis CSF 
index)
Yes, “there appears to be a statistically 
significant association between ALS and 
immunoreactivity to B burgdorferi”
Waisbren et al 
(1987)18
54 4 (no further information provided) Maybe; “it seems reasonable to find out if 
a patient with ALS does have B burgdor-
feri antibodies.”
Qureshi et al (2009)19 414 24 (5.8%) (ELISA)
4 (0.97%) (immunoblot)
No, it “is not likely to be either an etio-
logical factor or of significance in the 
differential diagnosis of motor neuron 
disease.”
Visser et al (2017)17 491 20 (4.1%) (immunoblot) versus 58/982 
(5.1%) in healthy controls
No, “this large case–control study provides 
evidence for a lack of association be-
tween B burgdorferi antibodies and ALS”
Abbreviations: ALS, amyotrophic lateral sclerosis; B., Borrelia; ELISA, enzyme-linked immunosorbent assay.
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burgdorferi and neural antigens may be of pathophysiological 
relevance.12 Electrophysiological data and few histopatho-
logical reports available mainly indicated axonal damage13 
by borrelia burgdorferi. The outer surface protein C may act 
as major virulence factor.14
In case series of ALS in endemic areas, a correlation was 
found between seropositivity for borrelia burgdorferi and 
ALS15 which was, however, not confirmed in later studies 
(see Table 2).16,17
It is controversially discussed, if microbiological tests for 
borrelia burgdorferi in CSF should be included in routine 
work-up of patients with assumed motor neuron disease.17,18 
Given the lack of objective biomarkers and relatively low 
sensitivity of the currently used diagnostic criteria,3,6,7 it is 
vital to exclude potentially treatable diseases in the differen-
tial diagnostic work-up of all patients not to miss seldom, but 
treatable differential diagnoses20 such as neuroborreliosis. 
Although rare, patient cases as described in Table 1 strongly 
advocate this notion. Therefore, Neuroborreliosis should be 
considered during an ALS work-up. However, false-positive 
CSF results do occur. For example, one systematic review on 
twenty neuroborreliosis case-control studies investigated ac-
curacy of serological tests. Their overall sensitivity was 77% 
(95%, confidence interval 67% to 85%) and specificity 93% 
(95%, confidence interval 88% to 96%).21 Thus, results of CSF 
in ALS work-up should be interpreted carefully in context 
of all clinical test results. Further studies investigating large 
series with neuroborreliosis to identify specific biomarkers 
applicable in differential diagnosis with ALS may be useful.
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